 | • レポートコード：MRC2305A008 • 出版社/出版日：Transparency Market Research / 2023年3月27日 • レポート形態：英文、PDF、193ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートによると、世界の止血弁市場規模が、2023年に161.3百万ドルから2031年の245.6百万ドルとなり、予測期間中に年平均4.8%で成長すると推測されています。本レポートは、止血弁の世界市場について徹底的に分析・調査を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（Yコネクタ、ダブルバルブ型、片手操作型、その他）分析、用途別（血管造影検査、血管形成術、介入性心臓病学・放射線医学、その他）分析、エンドユーザー別（病院、専門クリニック、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の項目を整理しています。また、Abbott Laboratories、B. Braun Melsungen AG、Boston Scientific Corporation、Teleflex Incorporated、Terumo Corporation、Merit Medical Systems, Inc.、Freudenberg Medical, LLC、Argon Medical Devices、Qosina Corp.、DeRoyal Industriesなど、主要企業情報を含んでいます。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の止血弁市場規模：製品別 - Yコネクタの市場規模 - ダブルバルブ型止血弁の市場規模 - 片手操作型止血弁の市場規模 - その他製品の市場規模 ・世界の止血弁市場規模：用途別 - 血管造影検査における市場規模 - 血管形成術における市場規模 - 介入性心臓病学・放射線医学における市場規模 - その他用途における市場規模 ・世界の止血弁市場規模：エンドユーザー別 - 病院における市場規模 - 専門クリニックにおける市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の止血弁市場規模：地域別 - 北米の止血弁市場規模 - ヨーロッパの止血弁市場規模 - アジア太平洋の止血弁市場規模 - 中南米の止血弁市場規模 - 中東・アフリカの止血弁市場規模 ・競争状況 |
Hemostasis Valves Market – Scope of Report
TMR’s report on the global hemostasis valves market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global hemostasis valves market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemostasis valves market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hemostasis valves market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemostasis valves market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemostasis valves market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemostasis valves market.
The report delves into the competitive landscape of the global hemostasis valves market. Key players operating in the global hemostasis valves market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemostasis valves market profiled in this report.
Key Questions Answered in Global Hemostasis Valves Market Report
• What is the sales/revenue generated by hemostasis valves across all regions during the forecast period?
• What are the opportunities in the global hemostasis valves market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Hemostasis Valves Market – Research Objectives and Research Approach
The comprehensive report on the global hemostasis valves market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global hemostasis valves market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemostasis valves market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis Valves Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis Valves Market Analysis and Forecast, 2017 – 2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Incidence and Prevalence
5.3. Regilatory Approval
5.4. COVID-19 Impact Analysis
6. Global Hemostasis Valves Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017 – 2031
6.3.1. Y-connectors
6.3.2. Double Valves
6.3.3. One-handed
6.3.4. Others
6.4. Market Attractiveness By Product Type
7. Global Hemostasis Valves Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017 – 2031
7.3.1. Angiography
7.3.2. Angioplasty
7.3.3. Interventional Cardiology & Radiology
7.3.4. Others
7.4. Market Attractiveness By Application
8. Global Hemostasis Valves Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 – 2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgery Centers
8.3.4. Others (Research Institutes)
8.4. Market Attractiveness By End-user
9. Global Hemostasis Valves Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Hemostasis Valves Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2017 – 2031
10.2.1. Y-connectors
10.2.2. Double Valves
10.2.3. One-handed
10.2.4. Others
10.3. Market Value Forecast By Application, 2017 – 2031
10.3.1. Angiography
10.3.2. Angioplasty
10.3.3. Interventional Cardiology & Radiology
10.3.4. Others
10.4. Market Value Forecast By End-user, 2017 – 2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Ambulatory Surgery Centers
10.4.4. Others (Research Institutes)
10.5. Market Value Forecast By Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemostasis Valves Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 – 2031
11.2.1. Y-connectors
11.2.2. Double Valves
11.2.3. One-handed
11.2.4. Others
11.3. Market Value Forecast By Application, 2017 – 2031
11.3.1. Angiography
11.3.2. Angioplasty
11.3.3. Interventional Cardiology & Radiology
11.3.4. Others
11.4. Market Value Forecast By End-user, 2017 – 2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Ambulatory Surgery Centers
11.4.4. Others (Research Institutes)
11.5. Market Value Forecast By Country, 2017 – 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Hemostasis Valves Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 – 2031
12.2.1. Y-connectors
12.2.2. Double Valves
12.2.3. One-handed
12.2.4. Others
12.3. Market Value Forecast By Application, 2017 – 2031
12.3.1. Angiography
12.3.2. Angioplasty
12.3.3. Interventional Cardiology & Radiology
12.3.4. Others
12.4. Market Value Forecast By End-user, 2017 – 2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Ambulatory Surgery Centers
12.4.4. Others (Research Institutes)
12.5. Market Value Forecast By Country, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country
13. Latin America Hemostasis Valves Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 – 2031
13.2.1. Y-connectors
13.2.2. Double Valves
13.2.3. One-handed
13.2.4. Others
13.3. Market Value Forecast By Application, 2017 – 2031
13.3.1. Angiography
13.3.2. Angioplasty
13.3.3. Interventional Cardiology & Radiology
13.3.4. Others
13.4. Market Value Forecast By End-user, 2017 – 2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Ambulatory Surgery Centers
13.4.4. Others (Research Institutes)
13.5. Market Value Forecast By Country, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Hemostasis Valves Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 – 2031
14.2.1. Y-connectors
14.2.2. Double Valves
14.2.3. One-handed
14.2.4. Others
14.3. Market Value Forecast By Application, 2017 – 2031
14.3.1. Angiography
14.3.2. Angioplasty
14.3.3. Interventional Cardiology & Radiology
14.3.4. Others
14.4. Market Value Forecast By End-user, 2017 – 2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Ambulatory Surgery Centers
14.4.4. Others (Research Institutes)
14.5. Market Value Forecast By Country, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis by Company (2022)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Test Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. B. Braun Melsungen AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Test Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Test Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Teleflex Incorporated
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Test Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Terumo Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Test Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Merit Medical Systems, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Test Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Freudenberg Medical, LLC
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Test Product Type Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Argon Medical Devices
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Test Product Type Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Qosina Corp.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Test Product Type Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. DeRoyal Industries
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Test Product Type Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview